Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis c outbreak investigation

Journal of Clinical Microbiology

Volumn 52, Issue 7, 2014, Pages 2650-2652

  Gao, Fengxiang ^a   Talbot, Elizabeth A ^a,b   Loring, Carol H ^a   Power, Jill J ^a   Dionne Odom, Jodie ^a,b   Alroy Preis, Sharon ^a   Jackson, Patricia ^a   Bean, Christine L ^a  

^a NEW HAMPSHIRE DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; EPIDEMIC; FEMALE; HEALTH CENTER; HEPATITIS C; HEPATITIS C RAPID TEST; HUMAN; IMMUNOLOGY TEST KIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; BLOOD; CROSS INFECTION; DIAGNOSTIC PROCEDURE; EVALUATION STUDY; PROCEDURES;

CLINICAL LABORATORY TECHNIQUES; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84903774784     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00132-14     Document Type: Article

References (15)

1. Smith BD, Drobeniuc J, Jewett A, Branson BM, Garfein RS, Teshale E, Kamili S, Weinbaum CM. 2011. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J. Infect. Dis. 204: 825-831.
2. Shivkumar S, Peeling R, Jafari Y, Joseph L, Pant Pai N. 2012. Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis. Ann. Intern. Med. 157:558-566.
3. U.S. Food and Drug Administration. 2013. OraQuick HCV rapid antibody test-P080027. U.S. Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm220489.htm.
4. U.S. Food and Drug Administration. 2011. CLIA waiver expands availability of rapid blood test for antibodies to the hepatitis C virus (HCV). U.S. Food and Drug Administration, Silver Spring, MD. http://www.fda-.gov/ForConsumers/ ByAudience/ForPatientAdvocates/ucm281524.htm.
5. Lee SR, Kardos KW, Schiff E, Berne CA, Mounzer K, Banks AT, Tatum HA, Friel TJ, Demicco MP, Lee WM, Eder SE, Monto A, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Unangst JL, Kriebel L, Feiss G, Roehler M. 2011. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. J. Virol. Methods 172:27-31.
6. Cha YJ, Park Q, Kang ES, Yoo BC, Park KU, Kim JW, Hwang YS, Kim MH. 2013. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann. Lab. Med. 33:184-189.
7. Lee SR, Yearwood GD, Guillon GB, Kurtz LA, Fischl M, Friel T, Berne CA, Kardos KW. 2010. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. J. Clin. Virol. 48:15-17.
8. New Hampshire Department of Health and Human Services. 23 December 2013, accession date. Hepatitis C outbreak investigation, Exeter Hospital. Public report. New Hampshire Department of Health and Human Services, Concord, NH. http://www.dhhs.nh.gov/dphs/cdcs/hepatitisc/documents/hepc-outbreak-rpt.pdf.
9. OraSure Technologies, Inc. 2011. OraQuick® HCV rapid antibody test package insert. OraSure Technologies, Inc., Bethlehem, PA.
10. Ortho Clinical Diagnostics. 2010. Hepatitis C virus encoded antigen (recombinant c22-3, c200 and NS5) ORTHO® HCV version 3.0 ELISA test system package insert. Ortho Clinical Diagnostics, Rochester, NY.
11. Ortho Clinical Diagnostics. 2010. Vitros Immunodiagnostics Products anti-HCV reagent pack, version 4.2, package insert. Ortho Clinical Diagnostics, Rochester, NY.
12. Roche Diagnostics. 2007. COBAS® AMPLICOR® hepatitis C virus test version 2.0 package insert. Roche Diagnostics, Indianapolis, IN.
13. CDC. 23 December 2013, accession date. Healthcare-associated hepatitis B and C outbreaks reported to the Centers for Disease Control and Prevention (CDC) in 2008-2012. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hepatitis/statistics/healthcareoutbreaktable.htm.
14. CDC. 2012. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recommend. Rep. 61(RR04):1-18.
15. CDC. 2013. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb. Mortal. Wkly. Rep. 62(18):362-365